Unlocking the potential of ctDNA for predicting tumor prognosis.
作者信息
Zhan Zhi-Qing, Cheng Zhangkai J
机构信息
Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou.
Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
出版信息
Int J Surg. 2025 Jan 1;111(1):1671-1672. doi: 10.1097/JS9.0000000000002000.
Abstract
摘要
相似文献
1
Unlocking the potential of ctDNA for predicting tumor prognosis.挖掘循环肿瘤DNA在预测肿瘤预后方面的潜力。
Int J Surg. 2025 Jan 1;111(1):1671-1672. doi: 10.1097/JS9.0000000000002000.
2
Liquid biopsy: unlocking the potentials of cell-free DNA.液体活检：释放游离DNA的潜力
Virchows Arch. 2017 Aug;471(2):147-154. doi: 10.1007/s00428-017-2137-8. Epub 2017 May 2.
3
Comparing baseline VAF in circulating tumor DNA and tumor tissues predicting prognosis of patients with colorectal cancer liver metastases after curative resection.比较结直肠癌肝转移患者根治性切除术后循环肿瘤 DNA 和肿瘤组织中基线 VAF 预测预后的价值。
Clin Res Hepatol Gastroenterol. 2024 Nov;48(9):102464. doi: 10.1016/j.clinre.2024.102464. Epub 2024 Sep 12.
4
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.对 KRAS 突变的循环肿瘤 DNA 进行纵向监测可预测胰腺癌患者的预后和治疗反应。
PLoS One. 2019 Dec 31;14(12):e0227366. doi: 10.1371/journal.pone.0227366. eCollection 2019.
5
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.构建整合 ctDNA 的风险分层模型，预测新辅助治疗乳腺癌的反应和生存。
BMC Med. 2023 Dec 12;21(1):493. doi: 10.1186/s12916-023-03163-4.
6
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.ctDNA 在预测局部晚期直肠癌新辅助放化疗反应和预后评估中的应用：一项前瞻性队列研究。
PLoS Med. 2021 Aug 31;18(8):e1003741. doi: 10.1371/journal.pmed.1003741. eCollection 2021 Aug.
7
Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.解锁癌症诊断的未来——ctDNA 液体活检在非小细胞肺癌中的前景与挑战。
Transl Res. 2024 Oct;272:41-53. doi: 10.1016/j.trsl.2024.05.014. Epub 2024 Jun 3.
8
The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.血液和肿瘤组织突变谱对头颈部鳞状细胞癌的预后和治疗价值。
Oncologist. 2021 Feb;26(2):e279-e289. doi: 10.1002/onco.13573. Epub 2020 Nov 20.
9
Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis.循环肿瘤 DNA 在淋巴瘤中的预后价值：一项荟萃分析。
Clin Exp Med. 2022 Feb;22(1):1-7. doi: 10.1007/s10238-021-00718-8. Epub 2021 May 15.
10
Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.动态监测循环肿瘤 DNA 预测结直肠肝转移切除术后辅助化疗的预后和疗效。
Theranostics. 2021 May 12;11(14):7018-7028. doi: 10.7150/thno.59644. eCollection 2021.
本文引用的文献
1
Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis.血浆循环肿瘤 DNA 与食管癌患者预后的关系：一项荟萃分析。
Int J Surg. 2024 Jul 1;110(7):4370-4381. doi: 10.1097/JS9.0000000000001373.
2
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.晚期前列腺癌中血浆 ctDNA 片段的预测和液体活检的预后意义。
Nat Commun. 2024 Feb 28;15(1):1828. doi: 10.1038/s41467-024-45475-w.
3
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.通过循环肿瘤 DNA 甲基化对 I 期至 III 期结直肠癌进行分子残留疾病的早期检测和风险分层。
JAMA Oncol. 2023 Jun 1;9(6):770-778. doi: 10.1001/jamaoncol.2023.0425.
4
Postoperative circulating tumor DNA combined with consensus molecular subtypes can better predict outcomes in stage III colon cancers: A prospective cohort study.术后循环肿瘤DNA联合共识分子亚型能更好地预测III期结肠癌的预后：一项前瞻性队列研究。
Eur J Cancer. 2022 Jul;169:198-209. doi: 10.1016/j.ejca.2022.04.010. Epub 2022 May 27.
5
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.循环肿瘤 DNA 在 III 期结直肠癌中的应用：超越微小残留病灶检测，评估辅助治疗疗效和复发的临床行为。
Clin Cancer Res. 2022 Feb 1;28(3):507-517. doi: 10.1158/1078-0432.CCR-21-2404. Epub 2021 Oct 8.
Zotero 插件